Global Pharmaceuticals & Biotech Breakout Stocks

PharmaEssentia

Market Cap: NT$621.6b

A biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan.

10x Genomics

Market Cap: US$7.5b

Develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific.

AbCellera Biologics

Market Cap: US$3.4b

Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.

Harbin Pharmaceutical Group

Market Cap: CN¥22.4b

Engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally.

GemPharmatech

Market Cap: CN¥16.6b

A contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide.

Lin BioScience

Market Cap: NT$75.5b

A drug development company, develops therapies for oncology, ophthalmology, and metabolic diseases.

Sino BiologicalInc

Market Cap: CN¥15.8b

Engages in the provision of recombinant protein and antibody reagents for life science researchers in China and internationally.

AcrobiosystemsLtd

Market Cap: CN¥15.1b

Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.

Marksans Pharma

Market Cap: ₹150.9b

Engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally.

HARBIN GLORIA PHARMACEUTICALS

Market Cap: CN¥10.1b

Engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China and internationally.

Anhui Wanbang Pharmaceutical TechnologyLtd

Market Cap: CN¥8.0b

Anhui Wanbang Pharmaceutical Technology Co.,Ltd.

Bide Pharmatech

Market Cap: CN¥7.2b

Engages in the research, development, production, and sale of drug molecule building blocks and scientific reagents in China.

Omeros

Market Cap: US$992.3m

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.

Boji Medical TechnologyLtd

Market Cap: CN¥6.6b

Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.

GlaxoSmithKlineE

Market Cap: ج.م43.5b

Engages in production of pharmaceutical chemicals.

Guizhou Sanli PharmaceuticalLtd

Market Cap: CN¥5.5b

Engages in the plantation, research, development, production, and sale of pharmaceutical products in China.

Aarti Pharmalabs

Market Cap: ₹77.2b

Manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally.

Xinjiang Bai Hua Cun Pharma TechLtd

Market Cap: CN¥5.3b

Engages in pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses.

Novoprotein Scientific

Market Cap: CN¥4.8b

Researches, develops, produces, and sells raw materials and technical solutions for bio-pharmaceutical enterprises and research institutions in Asia, Europe, the United States, and Oceania.

Shanghai Kai Kai Industry

Market Cap: CN¥3.5b

Engages in the wholesale and retail of pharmaceutical products in China.

OmniAb

Market Cap: US$497.2m

A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.

EI- Nile for Pharmaceuticals and Chemical Industries

Market Cap: ج.م20.5b

Develops, produces, and sells pharmaceutical products in Egypt.

Kwality Pharmaceuticals

Market Cap: ₹35.7b

Together with its subsidiary, manufactures finished pharmaceutical formulations in India and internationally.

Ind-Swift Laboratories

Market Cap: ₹26.5b

Develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally.

Fredun Pharmaceuticals

Market Cap: ₹25.6b

Manufactures and sells pharmaceutical formulations, dietary/herbal supplements, nutraceuticals, animal healthcare products, cosmeceuticals, mobility and rehabilitation products, and other healthcare products in India, Africa, Southeast Asia, Commonwealth of Independent States countries, MENA region, and Latin America.

AVITA Medical

Market Cap: US$251.1m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

PepGen

Market Cap: US$200.9m

A clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States.

Cardiol Therapeutics

Market Cap: CA$244.4m

A clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.

Memphis Pharmaceuticals & Chemical Industries

Market Cap: ج.م8.7b

Engages in the research, development, manufacture, marketing, and distribution of pharmaceutical products for human and veterinary use in Egypt and internationally.

October PharmaE

Market Cap: ج.م7.0b

Manufactures and sells pharmaceutical products in Egypt.

Gain Therapeutics

Market Cap: US$90.4m

A biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia.

Bilcare

Market Cap: ₹1.9b

Provides pharmaceutical packaging research solutions in India and internationally.

Pharmala Biotech Holdings

Market Cap: CA$18.6m

A biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community.

Revive Therapeutics

Market Cap: CA$15.2m

A life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders.

AquaBounty Technologies

Market Cap: US$7.1m

Operates as a land-based aquaculture company.

Dannex Ayrton Starwin

Market Cap: GH₵57.6m

Engages in the manufacturing, importing, and sale of pharmaceutical products in Ghana.